Mark L. Sundermeyer MD

Genitourinary Oncology

Associate Professor

4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 800-647-2098
Fax+1 314-362-3192

Dr. Sundermeyer is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sundermeyer's full profile Already have an account?

Summary

Dr. Mark Sundermeyer is an oncology specialist based in St. Louis, MO, with a subspecialty in genitourinary oncology. He completed his medical education at the University of Missouri-Columbia School of Medicine, followed by a residency in internal medicine and a fellowship in hematology and medical oncology at Temple University Hospital and Fox Chase Cancer Center. He is currently an Associate Professor at Washington University, previously serving as Medical Director at CMH-OHSU Knight Cancer Collaborative and Deputy Chief of the Hematology/Oncology Division at Asplundh Cancer Pavilion. His research has led to numerous publications, including studies on breast cancer and B-cell malignancies. He has been recognized as a Philadelphia Magazine Top Doctor and has received multiple CMS Meaningful Use Certifications.

Education & Training

Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
Temple University HospitalResidency, Internal Medicine, 2000 - 2003
University of Missouri-Columbia School of MedicineClass of 2000

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MO State Medical License 2023 - 2027
OR State Medical License 2020 - 2027
IL State Medical License 2024 - 2026
WA State Medical License 2021 - 2024
PA State Medical License 2001 - 2021
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Philadelphia Magazine Top Doctor Philadelphia Magazine, 2018-2020
CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017

Publications & Presentations

PubMed

Evaluating Interim Progression: First PosttherapyLu-PSMA SPECT/CT Relative to Baseline PSMA PET/CT.
Ashwin Singh Parihar, Farrokh Dehdashti, Niharika Pant, Shubha G Ravindra, Russell Pachynski
Journal of Nuclear Medicine. 2026-07-23
26 citations
Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base
Alina M. Mateo, Todd A. Pezzi, Mark L. Sundermeyer, Cynthia A. Kelley, V. Suzanne Klimberg
Annals of Surgical Oncology. 2017-04-01
11 citations
Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data...
Alina M. Mateo, Todd A. Pezzi, Mark L. Sundermeyer, Cynthia A. Kelley, Vicki Klimberg
Journal of Surgical Oncology. 2016-10-01